• TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury

  2026-09-08

  The reference study identifies TDRD9 as a suppressor of neutrophil cuproptosis and develops hyaluronic acid-coated peptide nanoparticles to deliver TDRD9 siRNA during Pseudomonas aeruginosa lung infection. Evidence from patient-derived neutrophils, mouse models, and human lung organoids connects TDRD9 silencing with reduced neutrophil accumulation, bacterial burden, inflammation, and tissue injury through the PD-L1/CD80/p38 MAPK axis.

• Capecitabine in Patient-Derived Tumor Assays

  2026-09-08

  Capecitabine is a tumor-activated fluoropyrimidine prodrug whose apparent activity can change when stromal cells are added to patient-derived models. This article explains how gastric cancer assembloids can improve assay design, mechanism-focused readouts, and translational interpretation.

• Oteseconazole (VT-1161) in Candida Research

  2026-09-07

  Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor suited to Candida susceptibility testing, resistant-isolate profiling, and mechanism-focused antifungal research. This workflow-oriented guide covers dilution design, controls, assay interpretation, troubleshooting, and how to translate planktonic results into more advanced antifungal studies.

• Resiniferatoxin (RTX) Workflows for TRPV1 Research

  2026-09-07

  Resiniferatoxin (RTX) provides a precision workflow for activating, functionally silencing, and validating TRPV1-positive sensory pathways. This guide translates its ultra-potent pharmacology into calcium-imaging, tissue, and translational pain assays while showing how a recent GERD study used RTX as a mechanistic validation tool.

• Oteseconazole: From MIC to DDI-Aware Assays

  2026-09-05

  Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor whose value extends beyond low Candida MICs. This article presents a DDI-aware assay framework that connects fungal potency, resistance testing, formulation, and transporter risk without confusing in vitro activity with clinical effectiveness.

• Methylprednisolone Sodium Succinate: Bench Workflows

  2026-09-04

  Build reproducible corticosteroid experiments with concentration controls, vehicle matching, and orthogonal inflammatory readouts. This guide translates product specifications and receptor-pharmacology principles into practical workflows for inflammation, immunology, leukocyte, and tumor-cell studies.

• CCK-8 Workflow for APL Cell Response Studies

  2026-09-04

  Build a practical CCK-8 workflow for measuring APL cell growth, drug response, and cytotoxicity without confusing metabolic activity with cell number. This guide translates retinoid-receptor findings into plate design, controls, dose-response analysis, and troubleshooting decisions.

• Dual-Network Microspheres for Disc Degeneration

  2026-09-03

  The reference study develops an elastic dual-network hydrogel microsphere that combines stimulus-responsive miRNA delivery with local inflammatory modulation for intervertebral disc degeneration. Its design links mechanical durability, oxidative-environment-triggered release, CD44-mediated cellular uptake, and coordinated control of apoptosis and intracellular oxidative stress.

• Gastrin I (human): Reliable Assay Workflows

  2026-09-03

  This scenario-driven guide shows how Gastrin I (human), SKU B5358, can improve experimental planning for viability, proliferation, cytotoxicity, and gastric acid secretion studies. It connects peptide handling, organoid-model selection, and orthogonal data interpretation to practical laboratory decisions.

• Hematoxylin and Eosin Staining Kit Guide

  2026-09-02

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for consistent tissue morphology visualization in paraffin-embedded, frozen, and cytological samples. It is intended for research workflows and morphological assessment only, not for diagnosis, clinical decisions, or regulated medical use.

• Hexose Diphosphate in Metabolic Assays

  2026-09-02

  Hexose diphosphate supports practical studies of glycolytic control, ischemic energy failure, and inflammation-linked metabolic remodeling. This workflow-focused guide explains how to prepare the water-soluble hexose phosphate, design interpretable cell and tissue assays, and distinguish its effects from the phosphoenolpyruvate mechanism reported in healthy-aging research.

• Cholecystokinin Octapeptide Ammonium: ANP Signaling

  2026-09-01

  Cholecystokinin octapeptide ammonium is a sulfated CCK-8 research reagent whose effects extend from GPCR activation to oxidative signaling and ANP release. This article focuses on the isolated-atria evidence and translates it into a causal, assay-design framework rather than a generic applications overview.

• Reactive Oxygen Species Assay Kit for OA Research

  2026-09-01

  Use the Reactive Oxygen Species Assay Kit to connect intracellular superoxide with cartilage senescence, matrix loss, and redox signaling. This DHE workflow combines live-cell measurement, positive-control validation, and pathway-level interpretation for osteoarthritis and related oxidative stress models.

• Reactive Oxygen Species Assay Kit for Superoxide

  2026-08-31

  A practical guide to using a dihydroethidium (DHE) probe for intracellular superoxide measurement in live-cell fibrosis and mitophagy experiments. The workflow connects red fluorescence with mitochondrial quality-control readouts while emphasizing controls, normalization, and troubleshooting.

• 28S rRNA Expansion Segments Build Nucleolar Layers

  2026-08-31

  Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural elements that can reconstitute layered nucleolar-like organization. Comparative, deletion, transfer, and reconstitution experiments connect evolutionary expansion of these RNA regions with the emergence of more complex nucleolar architecture.

7793 records 1/520 page Next 12345 下5页 Last page